Crown Bioscience is a global drug discovery and development services company headquartered in Santa Clara, California. The company provides preclinical research services to support drug discovery and development for pharmaceutical, biotechnology, and academic research institutions worldwide.
Crown Bioscience offers a wide range of services and solutions to support drug discovery and development, including preclinical efficacy testing, pharmacokinetic and toxicological studies, drug screening, biomarker identification, and disease model creation. The company’s expertise covers a variety of therapeutic areas, including oncology, inflammation, cardiovascular, metabolic, and neurological diseases.
Crown Bioscience has a global presence with operations in North America, Europe, and Asia-Pacific. The company’s team of experienced scientists and researchers work closely with clients to provide customized solutions tailored to their specific needs. Crown Bioscience’s mission is to accelerate drug discovery and development by providing high-quality, reliable research services and innovative solutions to help clients bring new therapies to market faster and more efficiently.